BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

5:45 PM
Apr 24, 2009
 |  BC Extra  |  Top Story

FDA approves J&J's Simponi

FDA approved a BLA from Johnson & Johnson (NYSE:JNJ) for once-monthly Simponi golimumab to treat...

Read the full 63 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >